maternal hemorrhage risk assessment presentation

Upload: fame77

Post on 30-May-2018

225 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/9/2019 Maternal Hemorrhage Risk Assessment Presentation

    1/36

    MATERNALMATERNALHEMORRHAGEHEMORRHAGE

  • 8/9/2019 Maternal Hemorrhage Risk Assessment Presentation

    2/36

    Prevention of MaternalPrevention of Maternal

    DeathDeath High Rate of Maternal Death due to hemorrhageHigh Rate of Maternal Death due to hemorrhage

    Most women who died of hemorrhage (97%) wereMost women who died of hemorrhage (97%) werehospitalized at the time of their deathhospitalized at the time of their death

    To reduce the risk of death the ACOG/DOHTo reduce the risk of death the ACOG/DOH

    recommends:recommends: Effective guidelines for maternal hemorrhageEffective guidelines for maternal hemorrhage

    Prompt recognition and response to hemorrhagePrompt recognition and response to hemorrhage

    DO NOT DELAY TRANSFUSION WHILEDO NOT DELAY TRANSFUSION WHILEAWAITING LAB RESULTS OR HEMODYNAMICAWAITING LAB RESULTS OR HEMODYNAMIC

    INSTABILITYINSTABILITY

  • 8/9/2019 Maternal Hemorrhage Risk Assessment Presentation

    3/36

    Prevention of Maternal DeathPrevention of Maternal Death

    RecommendationsRecommendations

    Effective guidelines to respond,Effective guidelines to respond,including emergency transfusion, withincluding emergency transfusion, with

    coordination among obstetricians,coordination among obstetricians,nurses, anesthesia and Blood Banknurses, anesthesia and Blood Bank

    Be vigilant to blood loss, if clinicalBe vigilant to blood loss, if clinicaljudgment indicates transfusion,judgment indicates transfusion, do notdo not

    delay awaiting lab resultsdelay awaiting lab results, slow blood, slow bloodloss can be life threateningloss can be life threatening

  • 8/9/2019 Maternal Hemorrhage Risk Assessment Presentation

    4/36

    Prevention of Maternal DeathPrevention of Maternal Death

    RecommendationsRecommendations

    Use fluid resuscitation and transfusion basedUse fluid resuscitation and transfusion based

    on estimated blood loss and expectation ofon estimated blood loss and expectation of

    continued bleedingcontinued bleeding

    Work with Labor and Delivery on MaternalWork with Labor and Delivery on Maternal

    Hemorrhage DrillsHemorrhage Drills

    Conduct Continuing Medical Education for theConduct Continuing Medical Education for the

    entire medical teamentire medical team

  • 8/9/2019 Maternal Hemorrhage Risk Assessment Presentation

    5/36

    Informed ConsentInformed Consent

    Identify patients who express concernsIdentify patients who express concernsabout receiving blood products for anyabout receiving blood products for anyreason (i.e Jehovah Witness)reason (i.e Jehovah Witness)

    Ensure that the patient has adequateEnsure that the patient has adequateopportunity to speak to an obstetrician andopportunity to speak to an obstetrician andan anesthesiologist regarding her concernsan anesthesiologist regarding her concernsand the risks/benefitsand the risks/benefits

    Ensure that the Consent/Refusal to BloodEnsure that the Consent/Refusal to BloodProducts form is signedProducts form is signed

  • 8/9/2019 Maternal Hemorrhage Risk Assessment Presentation

    6/36

  • 8/9/2019 Maternal Hemorrhage Risk Assessment Presentation

    7/36

    Risk AssessmentRisk Assessment

    for Hemorrhagefor Hemorrhage

  • 8/9/2019 Maternal Hemorrhage Risk Assessment Presentation

    8/36

    Low RiskLow Risk

    First or early second trimester D&CFirst or early second trimester D&Cwithout history of bleeding (scheduled)without history of bleeding (scheduled)

    CerclageCerclage

    Vaginal BirthVaginal Birth No previous uterine incisionNo previous uterine incision

    No history of bleeding problemsNo history of bleeding problems

    No history of PP hemorrhageNo history of PP hemorrhage

    Four or less previous vaginal birthsFour or less previous vaginal births

    Singleton pregnancySingleton pregnancy

  • 8/9/2019 Maternal Hemorrhage Risk Assessment Presentation

    9/36

    Low RiskLow Risk

    Send Hold specimen to the Blood BankSend Hold specimen to the Blood Bank

    If patients status changes, notify bloodIf patients status changes, notify blood

    bank to perform type and screen and/orbank to perform type and screen and/or

    type and cross matchtype and cross match Examples include need for c/section, PPExamples include need for c/section, PP

    hemorrhage, chorioamnionitis, prolongedhemorrhage, chorioamnionitis, prolonged

    labor and exposure to oxytocinlabor and exposure to oxytocin

  • 8/9/2019 Maternal Hemorrhage Risk Assessment Presentation

    10/36

    Moderate RiskModerate Risk

    VBACVBAC

    Cesarean sectionsCesarean sections

    Multiple gestations or macrosomiaMultiple gestations or macrosomia

    History of prior post partum hemorrhageHistory of prior post partum hemorrhage

    Uterine fibroidsUterine fibroids

    Mid to late second trimester D&Es orMid to late second trimester D&Es or

    induced vaginal birthsinduced vaginal births Other increased risks as designated byOther increased risks as designated by

    physicianphysician

  • 8/9/2019 Maternal Hemorrhage Risk Assessment Presentation

    11/36

    Moderate RiskModerate Risk

    Type and screen to Blood BankType and screen to Blood Bank

    CBC with plateletsCBC with platelets

    Additional labs as per OBAdditional labs as per OB Consider cell saver for JehovahConsider cell saver for Jehovah

    Witness or any other patient whoWitness or any other patient who

    refuses blood productsrefuses blood products

  • 8/9/2019 Maternal Hemorrhage Risk Assessment Presentation

    12/36

    High RiskHigh Risk

    Placenta previaPlacenta previa

    Suspected placenta accretaSuspected placenta accreta

    Hematocrit less than 26Hematocrit less than 26 Vaginal bleeding on admissionVaginal bleeding on admission

    Coagulation defectsCoagulation defects

    Other high risks as designated by theOther high risks as designated by thephysicianphysician

  • 8/9/2019 Maternal Hemorrhage Risk Assessment Presentation

    13/36

    High RiskHigh Risk

    Type and screen and cross match for 4 unitsType and screen and cross match for 4 units

    CBC, PT, PTT, FibrinogenCBC, PT, PTT, Fibrinogen

    Second large bore IVSecond large bore IV

    Anesthesia to prepare Hot LineAnesthesia to prepare Hot Line Cell saver team on stand-byCell saver team on stand-by

    1-800-235-57281-800-235-5728

    (****especially for Jehovahs Witness****)(****especially for Jehovahs Witness****)

  • 8/9/2019 Maternal Hemorrhage Risk Assessment Presentation

    14/36

    MATERNAL BLOOD VOLUMEMATERNAL BLOOD VOLUME

    Non pregnant femaleNon pregnant female

    3600 ml3600 ml

    Pregnant female (near term)Pregnant female (near term) 54005400

    mlml

  • 8/9/2019 Maternal Hemorrhage Risk Assessment Presentation

    15/36

    DEGREES OF BLOOD LOSSDEGREES OF BLOOD LOSS

    VolumeEstimate

    Percent Type

    500 ml or > 10-15% compensated

    1000-1500 ml 15-25% mild

    1500-2000 ml 25-35% moderate

    2000-3000 ml 35-50% severe

  • 8/9/2019 Maternal Hemorrhage Risk Assessment Presentation

    16/36

    Caveats for the PregnantCaveats for the Pregnant

    PatientPatient If the Obstetric Staff is consideringIf the Obstetric Staff is considering

    transfusing a pregnant patient anesthesiatransfusing a pregnant patient anesthesiashould be notifiedshould be notified

    Blood loss is almost alwaysBlood loss is almost always underestimatedunderestimated(especially after vaginal birth)(especially after vaginal birth) Pregnant patients can lose up to 40% ofPregnant patients can lose up to 40% of

    their blood volume (compared to 25% intheir blood volume (compared to 25% in

    non-pregnant patients) before showingnon-pregnant patients) before showingsigns of hemodynamic instabilitysigns of hemodynamic instability

    Dont wait for hypotension to startDont wait for hypotension to startreplacing volumereplacing volume

  • 8/9/2019 Maternal Hemorrhage Risk Assessment Presentation

    17/36

    Causes of PP HemorrhageCauses of PP Hemorrhage

    Uterine AtonyUterine Atony

    Lacerations to the cervix and genitalLacerations to the cervix and genital

    tracttract

    Retained placenta and otherRetained placenta and other

    placental abnormalitiesplacental abnormalities

    Coagulation disordersCoagulation disorders

  • 8/9/2019 Maternal Hemorrhage Risk Assessment Presentation

    18/36

    Risk Factors for UterineRisk Factors for Uterine

    AtonyAtony Multiple gestationMultiple gestation MacrosomiaMacrosomia PolyhydramniosPolyhydramnios

    High ParityHigh Parity Prolonged labor especially if augmentedProlonged labor especially if augmentedwith oxytocinwith oxytocin

    Precipitous laborPrecipitous labor

    ChorioamnionitisChorioamnionitis Use of tocolytic agentsUse of tocolytic agents Abnormal placentationAbnormal placentation

  • 8/9/2019 Maternal Hemorrhage Risk Assessment Presentation

    19/36

    Trauma to the Genital TractTrauma to the Genital Tract

    Large episiotomy, including

    extensions

    Lacerations of perineum, vagina orcervix

    Ruptured uterus

  • 8/9/2019 Maternal Hemorrhage Risk Assessment Presentation

    20/36

    Placental AbnormalitiesPlacental Abnormalities

    Retained placentaRetained placenta

    Abnormal placentationAbnormal placentation

    AccretaAccreta

    PercretaPercreta

    IncretaIncreta

    PreviaPrevia

  • 8/9/2019 Maternal Hemorrhage Risk Assessment Presentation

    21/36

    Coagulation AbnormalitiesCoagulation Abnormalities

    DIC (may result from excessive blood loss)

    Thrombocytopenia

    abruption

    ITP

    TTP

    Pre-eclampsia including HELLP Syndrome

    Anticardiolipin/Antiphospholipid Syndrome

  • 8/9/2019 Maternal Hemorrhage Risk Assessment Presentation

    22/36

    IDENTIFICATION ANDIDENTIFICATION AND

    EVALUATIONEVALUATION

    Assessment:Assessment:

    Mental StatusMental Status

    Vital Signs including BP, Pulse and OVital Signs including BP, Pulse and O22

    saturationsaturation

    Intake: Blood Products and FluidsIntake: Blood Products and Fluids

    Output: Urine and Blood LossOutput: Urine and Blood Loss

    Hemoglobin and HematocritHemoglobin and Hematocrit Assess uterine tone and vaginal bleedingAssess uterine tone and vaginal bleeding

  • 8/9/2019 Maternal Hemorrhage Risk Assessment Presentation

    23/36

    Identify Team LeadersIdentify Team Leaders

    (MD/RN)(MD/RN)

    Call Code Noelle

    MFM on-call

    AnesthesiaAttending

    Blood BankDirector

    Antepartum Back-

    up (if MFM isprimary OB)

    L&D NurseManager

    ADN

  • 8/9/2019 Maternal Hemorrhage Risk Assessment Presentation

    24/36

    MANAGEMENTMANAGEMENT

    Non-surgicalNon-surgical

    IDENTIFY CAUSE OF BLEEDING

    Examine :

    Uterus to r/o atony

    Uterus to r/o ruptureVagina to r/o laceration

  • 8/9/2019 Maternal Hemorrhage Risk Assessment Presentation

    25/36

    MANAGEMENTMANAGEMENT

    Non-surgicalNon-surgical ManagementManagement

    Atony:Atony: Firm Bimanual Compression

    Order

    Oxytocin infusion

    15-methyl prostaglandin F2alpha IM

    Second line:

    (methergine (if BP normal), PGE1, PGE2)

    MANAGEMENT: NonMANAGEMENT: Non

  • 8/9/2019 Maternal Hemorrhage Risk Assessment Presentation

    26/36

    MANAGEMENT: Non-MANAGEMENT: Non-

    surgicalsurgical

    Hypovolemic ShockHypovolemic Shock Management: Secure 2 large bore IVs, consider a central venous catheter

    Insert indwelling foley catheter

    Order:

    LR at desired infusion rate Second line NS with Y-Type infusion set

    Two units of PRBCs for stat infusion

    Cross match 4 additional units of PRBCs

    Thaw 4 units of FFP

    Supplemental O2 at 8-10 L Non re-breather mask

    MANAGEMENT: NonMANAGEMENT: Non

  • 8/9/2019 Maternal Hemorrhage Risk Assessment Presentation

    27/36

    MANAGEMENT: Non-MANAGEMENT: Non-

    surgicalsurgical

    NursingNursing Registered Nurses: Administer O2 at 8-10 L face mask

    Cardiorespiratory, BP and SAO2 monitors

    Secure 2 Large bore IVs

    Pick up orders as written

    Administer warmed IV Fluids

    Administer Blood Products

    Insert indwelling foley catheter

    Trendelenberg position

    Administer medications

    MANAGEMENT: NonMANAGEMENT: Non

  • 8/9/2019 Maternal Hemorrhage Risk Assessment Presentation

    28/36

    MANAGEMENT: Non-MANAGEMENT: Non-

    surgicalsurgical

    NursingNursing Nursing Station Clerks:

    Enter Lab and Blood Bank Orders

    Page all members of MaternalHemorrhage team

    Await addition instructions for: Cell Saver Team

    Gyn-Oncology Surgeon

    MANAGEMENT: NonMANAGEMENT: Non

  • 8/9/2019 Maternal Hemorrhage Risk Assessment Presentation

    29/36

    MANAGEMENT: Non-MANAGEMENT: Non-

    surgicalsurgical

    NursingNursing Clinical Assistants: Assists RN/MD as needed

    Prep OR; including gyn long,

    hysterectomy and/or gyn surgery trays

    Pick up blood products from Blood Bank

    Obtain Blood/Fluid Warmer

    Obtain Cell Saver Equipment from OR

  • 8/9/2019 Maternal Hemorrhage Risk Assessment Presentation

    30/36

    MANAGEMENT: SurgicalMANAGEMENT: Surgical

    OR PersonnelOR Personnel

    OB AttendingOB Attending

    MFM Back upMFM Back up

    OB Resident(s)OB Resident(s) AnesthesiaAnesthesia

    AttendingAttending

    AnesthesiaAnesthesia

    Resident(s)Resident(s)

    2 Circulating RNs2 Circulating RNs

    1 Scrub Tech/RN1 Scrub Tech/RN

    Gyn-Onc SurgeonGyn-Onc Surgeon

    (prn)(prn) InterventionalInterventional

    Radiology (prn)Radiology (prn)

    Cell SaverCell Saver

    Personnel (prn)Personnel (prn)

  • 8/9/2019 Maternal Hemorrhage Risk Assessment Presentation

    31/36

    MANAGEMENT: SurgicalMANAGEMENT: Surgical

    OR EquipmentOR EquipmentTraysTrays

    Gyn Long TrayGyn Long Tray

    Hysterectomy TrayHysterectomy Tray

    Gyn Surgery TrayGyn Surgery Tray

    Cell Saver EquipmentCell Saver Equipment

    Preparation of fibrin gluePreparation of fibrin glue

    (1-30 ml syringe with 2 vials Topical Thrombin + 0.5 ml of 10% CaCl, 1-(1-30 ml syringe with 2 vials Topical Thrombin + 0.5 ml of 10% CaCl, 1-

    30 ml syringe with 30 ml of cryoprecipitate, both attached to 18 g30 ml syringe with 30 ml of cryoprecipitate, both attached to 18 g

    angiocaths)angiocaths)

  • 8/9/2019 Maternal Hemorrhage Risk Assessment Presentation

    32/36

    MANAGEMENT: SurgicalMANAGEMENT: Surgical

    ANESTHESIAANESTHESIA

    Team CoordinatorTeam Coordinator

    Airway managementAirway management

    Hemodynamic MonitoringHemodynamic Monitoring FluidsFluids

    Blood ProductsBlood Products

    OutputOutput

  • 8/9/2019 Maternal Hemorrhage Risk Assessment Presentation

    33/36

    MANAGEMENT: SurgicalMANAGEMENT: Surgical

    OBSTETRICIAN/SURGEONOBSTETRICIAN/SURGEON Control Source of HemorrhageControl Source of Hemorrhage Perform indicated Procedure:Perform indicated Procedure:

    REPAIR LACERATIONREPAIR LACERATION

    BILATERAL UTERINE ARTERY LIGATIONBILATERAL UTERINE ARTERY LIGATION

    BILATERAL HYPOGASTRIC ARTERY LIGATIONBILATERAL HYPOGASTRIC ARTERY LIGATION

    HYSTERECTOMYHYSTERECTOMY

    Utilize additional resources if surgeryUtilize additional resources if surgerycontinues and emergency transfusion iscontinues and emergency transfusion is

    occurring (Gyn-Onc Surgeon)occurring (Gyn-Onc Surgeon) Consider Interventional RadiologyConsider Interventional Radiology

  • 8/9/2019 Maternal Hemorrhage Risk Assessment Presentation

    34/36

    MANAGEMENT: SurgicalMANAGEMENT: Surgical

    NURSINGNURSING Assist anesthesia as neededAssist anesthesia as needed

    Assist with surgery (scrub/circulate)Assist with surgery (scrub/circulate)

    Assess for the need for further additionalAssess for the need for further additionalsurgical expertisesurgical expertise

    Ongoing surgery with emergencyOngoing surgery with emergency

    transfusion continuingtransfusion continuing

    Obtain NICU as needed if infant undeliveredObtain NICU as needed if infant undelivered

    Obtain/administer medications as neededObtain/administer medications as needed

  • 8/9/2019 Maternal Hemorrhage Risk Assessment Presentation

    35/36

    Post-op DispositionPost-op Disposition

    Anesthesiologist and obstetrician willAnesthesiologist and obstetrician will

    determine post op disposition of thedetermine post op disposition of the

    patient and call appropriate consultspatient and call appropriate consults

    ( i.e. SICU attending)( i.e. SICU attending) All intubated patients must go to theAll intubated patients must go to the

    SICUSICU

    Other patients at anesthesiologistsOther patients at anesthesiologistsdiscretiondiscretion

    Nursing to give report to SICUNursing to give report to SICU

  • 8/9/2019 Maternal Hemorrhage Risk Assessment Presentation

    36/36

    SummarySummary

    Maternal hemorrhage remains the numberMaternal hemorrhage remains the number

    one cause of maternal death in NYSone cause of maternal death in NYS

    Identification of high risk patients canIdentification of high risk patients can

    prevent severe complicationsprevent severe complications Early intervention for the low risk patientEarly intervention for the low risk patient

    who starts to bleed is also crucialwho starts to bleed is also crucial

    Proper communication between nursing,Proper communication between nursing,OB, anesthesia and neonatology willOB, anesthesia and neonatology will

    provide best outcome for mother and babyprovide best outcome for mother and baby